Overview
Effects of Long Term Macrolide Antibiotic Therapy in Patients With COPD
Status:
Unknown status
Unknown status
Trial end date:
2006-03-01
2006-03-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this study is to determine whether long term treatment with oral erythromycin is effective in the treatment of subjects with Chronic Obstructive Pulmonary Disease (COPD) by reducing the number of exacerbations and the degree of airway inflammation.Phase:
Phase 2/Phase 3Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Royal Free and University College Medical SchoolTreatments:
Erythromycin
Erythromycin Estolate
Erythromycin Ethylsuccinate
Erythromycin stearate
Criteria
Inclusion Criteria:- Clinical Diagnosis of COPD
- Clinically stable for 6 weeks
- Able to Swallow Tablets
Exclusion Criteria:
- Clinically significant respiratory disease other than COPD
- Women of child bearing age
- Patients receiving existing Medication which may interact adversely with trial drug
- History of clinically significant liver disease